Guangxi Investment Group Co Ltd:電力:M&Aディール及び事業提携情報

◆英語タイトル:Guangxi Investment Group Co Ltd - Power - Deals and Alliances Profile
◆商品コード:DATA904C6920
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:電力
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Guangxi Investment Group Co Ltd (Guangxi Investment) is a diversified company. The company’s business segments include energy, aluminium, financial, cultural tourism, international business and medical and medical health business. Its energy business provides investments in the construction of power projects including Guangxi Natural Gas Pipeline Network project. Guangxi Investment’s aluminium business produces and distributes aluminium products in Guangxi, China. The company’s financial business segment offers securities, banking and insurance services, fund management, financial leasing, guarantee, small loans, small micro internet finance, gold investment and equity investment, among others. Its medical and medical health business provides pharmaceuticals, medical equipment, pharmaceutical logistics and healthy pension services. The company’s cultural tourism business operates theme park. Its international business provides international trade, international resources, energy, non-ferrous metal project investment, construction and operation management, warehousing logistics and transportation, industrial parks, and commercial real estate investment development and operation. Guangxi Investment is headquartered in Nanning, China.

Guangxi Investment Group Co Ltd – Power – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Power eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Guangxi Investment Group Co Ltd, Power, Deals By Year, 2012 to YTD 2018 5
Guangxi Investment Group Co Ltd, Power Deals By Type, 2012 to YTD 2018 6
Guangxi Investment Group Co Ltd, Power, Deals By Region, 2012 to YTD 2018 7
Guangxi Investment Group Co Ltd, Power, Deals By Sector, 2012 to YTD 2018 8
Guangxi Investment Group Co Ltd, Power, Deals Summary, 2012 to YTD 2018 9
Guangxi Investment Group Co Ltd, Power, Deal Details 10
Partnerships 10
China General Nuclear Forms Partnership with Guangxi Investment Group 10
Asset Transactions 11
Guiguan Electric Power Plans to Acquire Longtan Hydro Power Plant from China Datang, Guangxi Investment and Guizhou Industrial Investment for USD2.7 Billion 11
Acquisition 13
Guiguan Electric Power to Acquire LongTan Hydropower from China Datang, Guangxi Investment, Guizhou Industrial Investment for USD2.74 Billion 13
Guangxi Guiguan Electric Power To Acquire 85% Interest In LongTan Hydropower For US$2.4 Billion 15
Guangxi Investment Group Co Ltd – Key Competitors 17
Guangxi Investment Group Co Ltd – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Joint Venture 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Guangxi Investment Group Co Ltd, Power, Key Facts 2
Guangxi Investment Group Co Ltd, Power, Deals Summary, 2012 to YTD 2018 2
Guangxi Investment Group Co Ltd, Power, Deals By Year, 2012 to YTD 2018 5
Guangxi Investment Group Co Ltd, Power Deals By Type, 2012 to YTD 2018 6
Guangxi Investment Group Co Ltd, Power, Deals By Region, 2012 to YTD 2018 7
Guangxi Investment Group Co Ltd, Deals By Sector, 2012 to YTD 2018 8
Guangxi Investment Group Co Ltd, Power, Deals Summary, 2012 to YTD 2018 9
China General Nuclear Forms Partnership with Guangxi Investment Group 10
Guiguan Electric Power Plans to Acquire Longtan Hydro Power Plant from China Datang, Guangxi Investment and Guizhou Industrial Investment for USD2.7 Billion 11
Guiguan Electric Power to Acquire LongTan Hydropower from China Datang, Guangxi Investment, Guizhou Industrial Investment for USD2.74 Billion 13
Guangxi Guiguan Electric Power To Acquire 85% Interest In LongTan Hydropower For US$2.4 Billion 15
Guangxi Investment Group Co Ltd, Key Competitors 17
Guangxi Investment Group Co Ltd, Joint Venture 18

List of Figures
Guangxi Investment Group Co Ltd, Power, Deals by Type, 2012 to YTD 2018 2
Guangxi Investment Group Co Ltd, Power, Deals By Year, 2012 to YTD 2018 2
Guangxi Investment Group Co Ltd, Power, Deals By Region, 2012 to YTD 2018 2
Guangxi Investment Group Co Ltd, Power, Deals By Sector, 2012 to YTD 2018 2
Guangxi Investment Group Co Ltd, Power, Deals By Year, 2012 to YTD 2018 5
Guangxi Investment Group Co Ltd, Power, Deals by Type, 2012 to YTD 2018 6
Guangxi Investment Group Co Ltd, Power, Deals By Region, 2012 to YTD 2018 7
Guangxi Investment Group Co Ltd, Power, Deals by Sector, 2012 to YTD 2018 8

★海外企業調査レポート[Guangxi Investment Group Co Ltd:電力:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Suzano SA (SUZB5):企業の財務・戦略的SWOT分析
    Suzano SA (SUZB5) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Regal Petroleum plc (RPT):企業の財務・戦略的SWOT分析
    Summary Regal Petroleum Plc (Regal), a subsidiary of Energees Investments Ltd, is an oil and gas company that conducts reviews on oil and gas projects. The company operates two gas and condensate fields such as Mekhediviska - Golotovschinska and Svyrydivske located in Dneipner-Donets basin in the no …
  • Atomic Energy of Canada Ltd:企業の戦略的SWOT分析
    Atomic Energy of Canada Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Affibody AB:製薬・医療:M&Aディール及び事業提携情報
    Summary Affibody AB (Affibody) is a biotech company that discovers and develops next generation biopharmaceuticals and related drugs. The company discovers and develops drugs based on its proprietary technology platforms such as Albumod and Affibody molecules. Its Affibody molecules are a class of a …
  • Barratt Developments Plc:企業の戦略・SWOT・財務情報
    Barratt Developments Plc - Strategy, SWOT and Corporate Finance Report Summary Barratt Developments Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • The Lubrizol Corporation:企業の戦略・SWOT・財務分析
    The Lubrizol Corporation - Strategy, SWOT and Corporate Finance Report Summary The Lubrizol Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Bank Of Ireland (Uk) Plc
    Bank Of Ireland (Uk) Plc - Strategy, SWOT and Corporate Finance Report Summary Bank Of Ireland (Uk) Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Evoqua Water Technologies Corp (AQUA):企業の財務・戦略的SWOT分析
    Evoqua Water Technologies Corp (AQUA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Great-West Life & Annuity Insurance Co:企業の戦略的SWOT分析
    Great-West Life & Annuity Insurance Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and ma …
  • China Oilfield Services Ltd (2883):企業の財務・戦略的SWOT分析
    China Oilfield Services Ltd (2883) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • AIG Asia Pacific Insurance Pte. Ltd.:企業の戦略・SWOT・財務情報
    AIG Asia Pacific Insurance Pte. Ltd. - Strategy, SWOT and Corporate Finance Report Summary AIG Asia Pacific Insurance Pte. Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Ophthotech Corp (OPHT):企業の財務・戦略的SWOT分析
    Summary Ophthotech Corp (Ophthotech) is a biopharmaceutical company that develops novel therapeutics to treat ophthalmic diseases, with a focus on age-related and orphan retinal diseases. The company’s products include Zimura, a complement inhibitor for stargardt disease. It also provides Fovista, a …
  • GenomeDx Biosciences Inc:医療機器:M&Aディール及び事業提携情報
    Summary GenomeDx Biosciences Inc (GenomeDx) is a genomic information company developing solutions for prostate cancer treatment and the management of other urologic cancers. The company offers decipher prostate cancer classifier, a transformative genomic test that provides an assessment of tumor agg …
  • MeVis Medical Solutions AG (M3V):企業の財務・戦略的SWOT分析
    MeVis Medical Solutions AG (M3V) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • National Bank of Canada:企業の戦略・SWOT・財務分析
    National Bank of Canada - Strategy, SWOT and Corporate Finance Report Summary National Bank of Canada - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Ono Pharmaceutical Co Ltd (4528):企業の財務・戦略的SWOT分析
    Ono Pharmaceutical Co Ltd (4528) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Media-Saturn-Holding GmbH:戦略・SWOT・企業財務分析
    Media-Saturn-Holding GmbH - Strategy, SWOT and Corporate Finance Report Summary Media-Saturn-Holding GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Marinus Pharmaceuticals Inc (MRNS):製薬・医療:M&Aディール及び事業提携情報
    Summary Marinus Pharmaceuticals Inc (Marinus) is a clinical stage biopharmaceutical company that manufactures and commercializes therapeutics for the treatment of epilepsy, neuropsychiatric disorders and others diseases. The company’s pipeline product comprise ganaxolone is a CNS-selective GABAA mod …
  • Apoteket AB:企業の戦略的SWOT分析
    Apoteket AB - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Gecko Biomedical:企業の製品パイプライン分析2018
    Summary Gecko Biomedical (Gecko) is a life science company that provides polymer solutions for tissue reconstruction. The company offers a platform that validates the technology in surgical spaces, including peripheral nerve reconstruction, ophthalmology, urology, and orthopaedics. It also provides …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆